SU3. Preliminary Study for Association of Genome-Wide Significant Glutamate Receptor Schizophrenia Risk Variants With Clozapine Response
Author(s) -
Cheng Chen,
Arun K. Tiwari,
Clement C. Zai,
Danielle Tylor,
Steven G. Potkin,
Herbert Y. Meltzer,
Jeffrey Lieberman,
Daniel Mueller,
James L. Kennedy
Publication year - 2017
Publication title -
schizophrenia bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.823
H-Index - 190
eISSN - 1745-1707
pISSN - 0586-7614
DOI - 10.1093/schbul/sbx024.002
Subject(s) - clozapine , schizophrenia (object oriented programming) , pharmacogenetics , antipsychotic , medicine , brief psychiatric rating scale , single nucleotide polymorphism , genome wide association study , nmda receptor , allele , pharmacology , psychiatry , psychology , psychosis , genetics , genotype , receptor , biology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom